1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
Follow Colchicine: new trials by email Literature Review of Colchicine trials Research Report on Colchicine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage Colchicine 0.5 MG, Placebo - Colchicine, ICH - Intracerebral Hemorrhage | Phase 3 | Not yet recruiting | Population Health Research Institute | 1125 | 2026-09-30 | 2026-09-01 |
| Efficacy and Safety of Colchicine After PCI Colchicine 0.5 mg, Colchicine 0.375 mg, Placebo - Coronary Heart Disease, Percutaneous Coronary Intervention | Phase 3 | Active not recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 8862 | 2024-07-09 | 2026-09-03 |
| Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Colchicine, Placebo - Transcatheter Aortic Valve Replacement, Atrial Fibrillation New Onset | Phase 3 | Completed | Insel Gruppe AG, University Hospital Bern | 120 | 2021-09-21 | 2026-06-03 |
Cerebral Hemorrhage (1) · Coronary Disease (1) · Stroke (1)
Cardiovascular Diseases (2) · Vascular Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Heart Diseases (1) · Hemorrhage (1) · Intracranial Hemorrhages (1) · Myocardial Ischemia (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Colchicine (3)
Insel Gruppe AG, University Hospital Bern (1) · Population Health Research Institute (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (1) · Switzerland (1)
Aristeidis Katsanos, MD (1) · Ashkan Shoamanesh, MD (1) · Thomas Pilgrim, Prof. (1) · Xiang Cheng, MD (1)